BLTE
Price
$137.44
Change
+$7.82 (+6.03%)
Updated
Nov 28 closing price
Capitalization
4.52B
118 days until earnings call
Intraday BUY SELL Signals
RIGL
Price
$50.49
Change
-$0.47 (-0.92%)
Updated
Nov 28 closing price
Capitalization
916.46M
Intraday BUY SELL Signals
Interact to see
Advertisement

BLTE vs RIGL

Header iconBLTE vs RIGL Comparison
Open Charts BLTE vs RIGLBanner chart's image
Belite Bio
Price$137.44
Change+$7.82 (+6.03%)
Volume$75.29K
Capitalization4.52B
Rigel Pharmaceuticals
Price$50.49
Change-$0.47 (-0.92%)
Volume$275.7K
Capitalization916.46M
BLTE vs RIGL Comparison Chart in %
BLTE
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLTE vs. RIGL commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a StrongBuy and RIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (BLTE: $137.44 vs. RIGL: $50.49)
Brand notoriety: BLTE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 73% vs. RIGL: 44%
Market capitalization -- BLTE: $4.52B vs. RIGL: $916.46M
BLTE [@Biotechnology] is valued at $4.52B. RIGL’s [@Biotechnology] market capitalization is $916.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 1 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, RIGL is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 5 bullish TA indicator(s).

  • BLTE’s TA Score: 4 bullish, 4 bearish.
  • RIGL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а +14.00% price change this week, while RIGL (@Biotechnology) price change was +9.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

BLTE is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($4.52B) has a higher market cap than RIGL($916M). RIGL YTD gains are higher at: 200.178 vs. BLTE (117.813). RIGL has higher annual earnings (EBITDA): 109M vs. BLTE (-50.43M). RIGL has higher revenues than BLTE: RIGL (268M) vs BLTE (0).
BLTERIGLBLTE / RIGL
Capitalization4.52B916M494%
EBITDA-50.43M109M-46%
Gain YTD117.813200.17859%
P/E RatioN/A8.16-
Revenue0268M-
Total CashN/A108M-
Total DebtN/A61M-
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
8
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLTERIGL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEIAX53.300.31
+0.59%
MFS Value A
BLPIX82.99N/A
N/A
ProFunds Bull Inv
TISBX26.87N/A
N/A
Nuveen Small Cap Blend Idx R6
CIOIX20.25N/A
N/A
Causeway International Opps Inst
IOGPX7.60N/A
N/A
Voya Global Insights Portfolio S2

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+6.03%
RAIN - BLTE
48%
Loosely correlated
+1.76%
ROIV - BLTE
25%
Poorly correlated
-0.29%
ACOG - BLTE
24%
Poorly correlated
-1.15%
RIGL - BLTE
23%
Poorly correlated
-0.92%
AGIO - BLTE
22%
Poorly correlated
+0.55%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with AGIO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-0.92%
AGIO - RIGL
37%
Loosely correlated
+0.55%
FTRE - RIGL
35%
Loosely correlated
+0.63%
NEVPF - RIGL
34%
Loosely correlated
N/A
AKBA - RIGL
33%
Loosely correlated
-0.63%
RNA - RIGL
33%
Poorly correlated
+0.20%
More